Roche Holding AG (RHHBY)
31.00
+0.10
(+0.32%)
USD |
OTCM |
May 10, 12:29
Roche Price to Book Value: 5.665 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 5.647 |
| May 08, 2024 | 5.559 |
| May 07, 2024 | 5.57 |
| May 06, 2024 | 5.499 |
| May 03, 2024 | 5.451 |
| May 02, 2024 | 5.347 |
| May 01, 2024 | 5.437 |
| April 30, 2024 | 5.449 |
| April 29, 2024 | 5.543 |
| April 26, 2024 | 5.528 |
| April 25, 2024 | 5.486 |
| April 24, 2024 | 5.581 |
| April 23, 2024 | 5.709 |
| April 22, 2024 | 5.649 |
| April 19, 2024 | 5.557 |
| April 18, 2024 | 5.491 |
| April 17, 2024 | 5.497 |
| April 16, 2024 | 5.524 |
| April 15, 2024 | 5.588 |
| April 12, 2024 | 5.590 |
| April 11, 2024 | 5.658 |
| April 10, 2024 | 5.590 |
| April 09, 2024 | 5.603 |
| April 08, 2024 | 5.517 |
| April 05, 2024 | 5.526 |
| Date | Value |
|---|---|
| April 04, 2024 | 5.619 |
| April 03, 2024 | 5.720 |
| April 02, 2024 | 5.734 |
| April 01, 2024 | 5.839 |
| March 28, 2024 | 5.833 |
| March 27, 2024 | 5.722 |
| March 26, 2024 | 5.722 |
| March 25, 2024 | 5.718 |
| March 22, 2024 | 5.724 |
| March 21, 2024 | 5.724 |
| March 20, 2024 | 5.961 |
| March 19, 2024 | 5.870 |
| March 18, 2024 | 5.881 |
| March 15, 2024 | 5.965 |
| March 14, 2024 | 6.010 |
| March 13, 2024 | 6.254 |
| March 12, 2024 | 6.423 |
| March 11, 2024 | 6.325 |
| March 08, 2024 | 6.195 |
| March 07, 2024 | 6.171 |
| March 06, 2024 | 6.116 |
| March 05, 2024 | 6.058 |
| March 04, 2024 | 6.009 |
| March 01, 2024 | 6.045 |
| February 29, 2024 | 5.981 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.347
Minimum
May 02 2024
12.77
Maximum
Apr 08 2022
8.483
Average
8.355
Median
Price to Book Value Benchmarks
| Novartis AG | 5.244 |
| Pfizer Inc | 1.721 |
| ADC Therapeutics SA | -- |
| Lonza Group Ltd | 3.723 |
| AC Immune SA | 1.195 |
Price to Book Value Related Metrics
| PE Ratio | 15.49 |
| PS Ratio | 2.944 |
| Price to Free Cash Flow | 15.55 |
| Price | 31.00 |
| Earnings Yield | 6.45% |
| Market Cap | 197.72B |
| Operating PE Ratio | 11.58 |
| Normalized PE Ratio | 15.31 |